HSL Mobile App
Bafna Pharmaceuticals Ltd
30 May 2026 12:00 AM
Bafna Pharmaceuticals standalone net profit rises 109.92% in the March 2026 quarter,
Net profit of Bafna Pharmaceuticals rose 109.92% to Rs 2.75 crore in the quarter ended March 2026 as against Rs 1.31 crore during the previous quarter ended March 2025. Sales rose 8.14% to Rs 42.24 crore in the quarter ended March 2026 as against Rs 39.06 crore during the previous quarter ended March 2025.For the full year,net profit rose 167.47% to Rs 11.10 crore in the year ended March 2026 as against Rs 4.15 crore during the previous year ended March 2025. Sales rose 3.26% to Rs 150.62 crore in the year ended March 2026 as against Rs 145.86 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales42.2439.06 8 150.62145.86 3 OPM %8.407.96 -10.587.66 - PBDT4.283.32 29 17.0411.19 52 PBT2.623.10 -15 10.976.30 74 NP2.751.31 110 11.104.15 167 Powered by Capital Market - Live News
Bafna Pharmaceuticals Ltd
22 May 2026 12:00 AM
Bafna Pharmaceuticals announces board meeting date,
Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 May 2026.
Bafna Pharmaceuticals Ltd
12 Feb 2026 12:00 AM
Bafna Pharmaceuticals standalone net profit rises 93.68% in the December 2025 quarter,
Net profit of Bafna Pharmaceuticals rose 93.68% to Rs 1.84 crore in the quarter ended December 2025 as against Rs 0.95 crore during the previous quarter ended December 2024. Sales rose 15.37% to Rs 38.29 crore in the quarter ended December 2025 as against Rs 33.19 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales38.2933.19 15 OPM %7.979.25 - PBDT3.412.62 30 PBT1.840.96 92 NP1.840.95 94 Powered by Capital Market - Live News
Bafna Pharmaceuticals Ltd
06 Feb 2026 12:00 AM
Bafna Pharmaceuticals announces board meeting date,
Bafna Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 February 2026.Powered by Capital Market - Live News
Bafna Pharmaceuticals Ltd
12 Nov 2025 12:00 AM
Bafna Pharmaceuticals standalone net profit rises 19.08% in the September 2025 quarter,
Net profit of Bafna Pharmaceuticals rose 19.08% to Rs 3.12 crore in the quarter ended September 2025 as against Rs 2.62 crore during the previous quarter ended September 2024. Sales declined 12.03% to Rs 35.47 crore in the quarter ended September 2025 as against Rs 40.32 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales35.4740.32 -12 OPM %12.049.42 - PBDT4.594.20 9 PBT3.122.62 19 NP3.122.62 19 Powered by Capital Market - Live News
Subscribe for our
newsletter
newsletter
